Status:
COMPLETED
Prevalence of H.Pylori in Patients With Acne Vulgaris Acne Vulgaris
Lead Sponsor:
Sohag University
Conditions:
Helicobacter Pylori Infection
Acne Vulgaris
Eligibility:
All Genders
12-60 years
Brief Summary
The objective of the study is to investigate prevalence of H.Pylori infection among acne vulgaris patients.
Detailed Description
The study included patients with acne vulgaris and healthy control participants. The study recruited both sexes, all grades of acne, adolescents and young adults. All patients were subjected to compl...
Eligibility Criteria
Inclusion
- Acne vulgaris patients
- Healthy volunteers (control)
Exclusion
- Patients with a history of drug intake that affects H. Pylori such as proton-pump inhibitors, clarithromycin, tetracyclines, amoxicillin or metronidazole within previous two weeks were excluded.
Key Trial Info
Start Date :
March 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2018
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03411733
Start Date
March 1 2017
End Date
March 1 2018
Last Update
May 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dermatology outpatient clinic, Sohag University Hospital
Sohag, Egypt, 82524